1d
News Medical on MSNGLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patientsResearchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.
7m
ScienceAlert on MSNNew Protein Discovery Could Rival Ozempic With Fewer Side EffectsScientists have discovered a naturally-occurring molecule that aids appetite control and weight loss so well, it may compete ...
Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase ...
7h
Discover Magazine on MSNNew Molecule Competes with Ozempic, Showing Fewer Side EffectsA naturally occurring molecule that works as effectively as other semaglutide-based drugs — without the common side effects — ...
CagriSema from Novo Nordisk activates both GLP-1 and amylin receptors. It is currently the subject of several clinical trials ...
The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...
There used to be no specific treatments for heart failure with preserved ejection fraction, but recent clinical trials show ...
A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide—also known as ...
If you’ve been paying attention to the weight loss world, you’ve probably heard about GLP-1 receptor agonists like Ozempic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results